glp 1 drugs and dementia GLP-1 Drug Fails to Quell Alzheimer's in Novo Nordisk Trials Prevention of Dementia with GLP-1
Description
The secondary outcome was all-cause mortality
Yatrmclarn bu deiimlere ayak uydurmas ve uzun vadeli stratejiler gelitirmesi gerekiyor
Beyond the health impacts, the global economic cost of obesity is predicted to hit $3 trillion annually by the end of this decade, the WHO said
This contributes to prolonged feelings of fullness and can help reduce overall food intake, aiding in weight loss or management in obesity treatment
10.1038/s44355-024-00014-8 78 LeeM
